Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria

Anna-Elisabeth Minder, Xiaoye Schneider-Yin, Henryk Zulewski, Christoph E. Minder, Elisabeth I. Minder

Open source

DOI
10.3390/life13041066
Published
2023-04-21
Container
Life
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life13041066,
  title = {Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria},
  author = {Anna-Elisabeth Minder and Xiaoye Schneider-Yin and Henryk Zulewski and Christoph E. Minder and Elisabeth I. Minder},
  year = {2023},
  journal = {Life},
  doi = {10.3390/life13041066},
  url = {https://doi.org/10.3390/life13041066}
}

RIS

TY  - JOUR
TI  - Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
AU  - Anna-Elisabeth Minder
AU  - Xiaoye Schneider-Yin
AU  - Henryk Zulewski
AU  - Christoph E. Minder
AU  - Elisabeth I. Minder
PY  - 2023
JO  - Life
DO  - 10.3390/life13041066
UR  - https://doi.org/10.3390/life13041066
ER  - 

APA

Minder, A., Schneider-Yin, X., Zulewski, H., Minder, C. E., & Minder, E. I. (2023). Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria. Life. https://doi.org/10.3390/life13041066

Source records